Brandinium

Trademark search for:

ALBUGEN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2003-04-10 — Application filed
  • 2003-09-15 — Assigned to examiner
  • 2003-09-17 — Final disposition recorded
  • 2004-03-15 — Paper received
  • 2004-03-15 — Correspondence received in law office
  • 2004-04-08 — Letter of suspension mailed
  • 2004-08-30 — Paper received
  • 2004-08-30 — Correspondence received in law office
  • 2004-09-09 — Amendment from applicant entered
  • 2004-09-09 — Assigned to lie
  • 2004-09-15 — Suspension letter written
  • 2004-09-15 — Letter of suspension e-mailed
  • 2005-03-11 — Correspondence received in law office
  • 2005-03-15 — Suspension inquiry written
  • 2005-03-15 — Inquiry to suspension e-mailed
  • 2005-04-11 — Paper received
  • 2005-04-20 — Amendment from applicant entered
  • 2005-05-12 — Suspension letter written
  • 2005-05-12 — Letter of suspension e-mailed
  • 2005-07-18 — Teas change of correspondence received
  • 2005-09-02 — Paper received
  • 2005-09-02 — Correspondence received in law office
  • 2005-09-16 — Amendment from applicant entered
  • 2005-10-07 — Suspension letter written
  • 2005-10-07 — Correspondence e-mailed
  • 2006-04-24 — Suspension inquiry written
  • 2006-04-24 — Inquiry to suspension e-mailed
  • 2006-05-02 — Paper received
  • 2006-05-02 — Correspondence received in law office
  • 2006-06-10 — Amendment from applicant entered
  • 2006-06-12 — Suspension letter written
  • 2006-06-12 — Letter of suspension e-mailed
  • 2006-07-03 — Paper received
  • 2006-07-03 — Correspondence received in law office
  • 2006-08-07 — Amendment from applicant entered
  • 2006-08-08 — Final disposition recorded
  • 2006-08-08 — Final disposition recorded
  • 2006-08-14 — Paper received
  • 2006-08-14 — Correspondence received in law office
  • 2006-09-25 — Amendment from applicant entered
  • 2006-10-16 — Office action issued
  • 2006-10-16 — Office action issued
  • 2006-11-08 — Automatic update of assignment of ownership
  • 2007-04-19 — Paper received
  • 2007-05-11 — Amendment from applicant entered
  • 2007-05-11 — Assigned to lie
  • 2007-05-11 — Correspondence received in law office
  • 2007-06-01 — Suspension letter written
  • 2007-06-01 — Letter of suspension e-mailed
  • 2007-06-05 — Approved for pub - principal register
  • 2007-06-05 — Law office publication review completed
  • 2007-06-15 — Withdrawn from pub - og review query
  • 2007-07-02 — Previous allowance count withdrawn
  • 2007-07-05 — Final disposition recorded
  • 2007-07-05 — Final disposition recorded
  • 2007-07-05 — Final disposition recorded
  • 2007-12-11 — Paper received
  • 2007-12-12 — Automatic update of assignment of ownership
  • 2007-12-12 — Examiners amendment -written
  • 2007-12-12 — Approved for pub - principal register
  • 2007-12-12 — Approved for pub - principal register
  • 2007-12-12 — Amendment from applicant entered
  • 2007-12-12 — Examiners amendment e-mailed
  • 2007-12-12 — Notification of examiners amendment e-mailed
  • 2007-12-12 — Examiner's amendment entered
  • 2007-12-12 — Previous allowance count withdrawn
  • 2007-12-12 — Correspondence received in law office
  • 2007-12-13 — Law office publication review completed
  • 2007-12-26 — Notice of publication
  • 2008-01-15 — Published for opposition
  • 2008-01-22 — Post publication amendment - entered
  • 2008-04-01 — Registered-principal register
  • 2012-02-08 — Automatic update of assignment of ownership
  • 2014-11-07 — Cancelled sec. 8 (6-yr)
  • 2014-11-07 — Final status recorded

Owner Information

NOVOZYMES BIOPHARMA DK A/S
BAGSVAERD DK
NOVOZYMES BIOPHARMA UK LIMITED
NOTTINGHAM, NG7 1FD GB
NOVOZYMES BIOPHARMA UK LIMITED
NOTTINGHAM, NG7 1FD GB
NOVOZYMES BIOPHARMA UK LIMITED
NOTTINGHAM, NG7 1FD GB
NOVOZYMES DELTA LIMITED
NOTTINGHAM GB
Delta Biotechnology Limited
Nottingham GB

Correspondent

SUSAN UPTON DOUGLASS FROSS ZELNICK LEHRMAN & ZISSU PC
866 UNITED NATIONS PLZ
NEW YORK, NY 10017-1822
UNITED STATES

Filing Details

Filing Date:
2003-04-10
Status Date:
2014-11-07
Category:
Pharmaceuticals
Filing Year:
1991

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.